Thrombosis: Difference between revisions

Jump to navigation Jump to search
Line 35: Line 35:
{{MedCondContrAbs
{{MedCondContrAbs


|MedCond = Deep vein thrombosis|Norethindrone acetate and Ethinyl estradiol|Norgestimate and Ethinyl estradiol}}
|MedCond = Deep vein thrombosis|Norethindrone acetate and Ethinyl estradiol|Norgestimate and Ethinyl estradiol|Norgestrel and Ethinyl estradiol}}


==Related Chapters==
==Related Chapters==

Revision as of 20:49, 30 October 2014

Thrombosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Classification

Arterial
Venous
Arterial and Venous Thrombosis: Differences and Similarities

Causes

Site of Thrombosis

Arterial
Venous

Differentiating Thrombosis from other Diseases

Arterial
Venous

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Evaluation

Treatment

Risk Factor Modifications

Prevention

Thrombosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombosis

CDC onThrombosis

Thrombosis in the news

Blogs on Thrombosis

to Hospitals Treating Thrombosis

Risk calculators and risk factors for Thrombosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

Arterial | Venous | Arterial and Venous Thrombosis: Differences and Similarities

Causes

Site of Thrombosis

Arterial | Venous

Differentiating Thrombosis from other Diseases

Arterial | Venous

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Evaluation

Treatment

Risk Factor Modifications | Prevention

Contraindicated medications

{{MedCondContrAbs

|MedCond =Deep vein thrombosis|

Contraindicated medications

Deep vein thrombosis is considered an absolute contraindication to the use of the following medications:

Related Chapters

Template:WH Template:WS